 |
|
|
| |
-
Surveillance for Adverse
Events
Associated with Anthrax Vaccination - U.S. Department of Defense,
1998-2000
Morbidity and Mortality Weekly Report [Morb. Mortal. Weekly Rep.], vol.
49, no. 16, pp. 341-345, Apr 2000
-
Current status of immunization
against anthrax: old vaccines may be here to stay for a while
Current Opinion in Infectious Diseases [Curr. Opin. Infect. Dis.], vol.
13, no. 2, pp. 113-120, Apr 2000
-
Protection against Anthrax
Lethal
Toxin Challenge by Genetic Immunization with a Plasmid Encoding the Lethal
Factor Protein
Infection and Immunity [Infect. Immun.], vol. 69, no. 7, pp. 4509-4515,
Jul 2001
-
Attenuated Nontoxinogenic and
Nonencapsulated Recombinant Bacillus anthracis Spore Vaccines Protect
against Anthrax
Infection and Immunity [Infect. Immun.], vol. 68, no. 8, pp. 4549-4558,
Aug 2000
-
Anthrax vaccine: increasing
intervals between the first two doses enhances antibody response in
humans
Vaccine, vol. 19, no. 2-3, pp. 213-216, 15 Sep 2000
-
Search for Correlates of
Protective
Immunity Conferred by Anthrax Vaccine
Infection and Immunity [Infect. Immun.], vol. 69, no. 5, pp. 2888-2893,
May 2001
-
Efficacy of a human anthrax
vaccine
in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus
anthracis isolates of diverse geographical origin
Vaccine, vol. 19, no. 23-24, pp. 3241-3247, 30 Apr 2001
-
Characterization of Bacillus
anthracis strains used for vaccination
Journal of Applied Microbiology [J. Appl. Microbiol.], vol. 88, no. 4,
pp. 648-654, Apr 2000
-
Genetically modified anthrax
lethal
toxin safely delivers whole HIV protein antigens into the cytosol to induce
T cell immunity
Proceedings of the National Academy of Sciences, USA [Proc. Natl. Acad.
Sci. USA], vol. 97, no. 14, pp. 8027-8032, 5 Jul 2000
-
Role of Furin in Delivery of a
CTL
Epitope of an Anthrax Toxin-Fusion Protein
Microbiology and Immunology [Microbiol. Immunol.], vol. 45, no. 2, pp.
119-125, 2001
-
The Anthrax Vaccine: A
Question of
Safety
Clinical Microbiology Newsletter [Clin. Microbiol. Newsl.], vol. 23,
no. 7, pp. 51-54, 1 Apr 2001
-
Constitutive Expression of
Protective Antigen Gene of Bacillus anthracis in Escherichia coli
Biochemical and Biophysical Research Communications [Biochem. Biophys.
Res. Commun.], vol. 283, no. 2, pp. 308-315, 4 May 2001
-
Delayed Life-Threatening
Reaction
to Anthrax Vaccine
Journal of Toxicology: Clinical Toxicology [J. Toxicol.: Clin.
Toxicol.], vol. 39, no. 1, pp. 81-84, 2001
-
Use of Anthrax Vaccine in the
United States: Recommendations of the Advisory Committee on Immunization
Practices
Journal of Toxicology: Clinical Toxicology [J. Toxicol.: Clin.
Toxicol.], vol. 39, no. 1, pp. 85-100, 2001
-
Detection of anthrax vaccine
virulence factors by polymerase chain reaction
Vaccine, vol. 19, no. 30, pp. 4214-4218, 20 Jul 2001
|
|
 |
|
 |
|
|
